Molina Healthcare, Inc. is a managed care company headquartered in Long Beach, California, United States. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| MOH | MOLINA HEALTHCARE, INC. | 2025-12-02 08:04:44 | 145.7 | 0.62 | 0.43 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MOH | 0001179929 | MOLINA HEALTHCARE, INC. | US60855R1005 | 549300NQQCEQ46YHZ591 | 134204626 | NYSE | 6324 | Hospital & Medical Service Plans | 1231 | DE | 200 OCEANGATE, SUITE 100 | LONG BEACH | CA | 90802 | UNITED STATES | US | 5624353666 | 200 OCEANGATE, SUITE 100, LONG BEACH, CA, 90802 | 200 OCEANGATE, SUITE 100, LONG BEACH, CA, 90802 | MOLINA HEALTHCARE INC | Healthcare | 1980 | Joseph Zubretsky | 18,000 | http://molinahealthcare.com | 17,200,000,000 | — | 51,400,000 | Molina Healthcare, Inc. is a managed care company headquartered in Long Beach, California, United States. The company provides health insurance to individuals through government programs such as Medicaid and Medicare. | 2025-11-27 15:39:58 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 17,200,000,000 | -200,000,000 | -1.1494 | 55,500,000 | -2,900,000 | -4.9658 |
| 2023 | 17,400,000,000 | 1,300,000,000 | 8.0745 | 58,400,000 | 500,000 | 0.8636 |
| 2022 | 16,100,000,000 | 1,400,000,000 | 9.5238 | 57,900,000 | -500,000 | -0.8562 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| James E. Woys | Chief Operating Officer | 2024 | 800,000 | — | 4,500,154 | 840,000 | 56,503 | 6,196,657 |
| Jeff D. Barlow | Chief Legal Officer, Secretary | 2024 | 685,000 | — | 3,199,903 | 719,250 | 50,837 | 4,830,168 |
| Joseph M. Zubretsky | Chief Executive Officer, President | 2024 | 1,600,000 | — | 16,200,092 | 3,360,000 | 784,017 | 21,944,109 |
| Mark L. Keim | Chief Financial Officer | 2024 | 850,000 | — | 5,000,043 | 892,500 | 303,326 | 7,045,869 |
| Debra J. Bacon | Executive Vice President | 2024 | 675,000 | — | 2,200,127 | 708,750 | 47,831 | 3,636,123 |
| Fiscal Year | Employee Count |
|---|---|
| 2022 | 15,000 |
| 2021 | 14,000 |
| 2020 | 10,500 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 40,650,000,000 | 34,072,000,000 | 31,974,000,000 |
| Cost Of Revenue | 34,428,000,000 | 28,669,000,000 | 27,175,000,000 |
| Gross Profit | 2,979,000,000 | 2,973,000,000 | 2,981,000,000 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 2,743,000,000 | 2,462,000,000 | 2,311,000,000 |
| Operating Expenses | 38,943,000,000 | 32,499,000,000 | 30,801,000,000 |
| Operating Income | 1,707,000,000 | 1,573,000,000 | 1,173,000,000 |
| Net Income | 1,179,000,000 | 1,091,000,000 | 792,000,000 |
| Earnings Per Share Basic | 20.52 | 18.91 | 13.72 |
| Earnings Per Share Diluted | 20.42 | 18.77 | 13.55 |
| Weighted Average Shares Outstanding Basic | 57,400,000 | 57,700,000 | 57,800,000 |
| Weighted Average Shares Outstanding Diluted | 57,700,000 | 58,100,000 | 58,500,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 4,662,000,000 | 4,848,000,000 | 4,006,000,000 |
| Marketable Securities Current | 4,325,000,000 | 4,259,000,000 | 3,499,000,000 |
| Accounts Receivable | 3,299,000,000 | 3,104,000,000 | 2,302,000,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 12,773,000,000 | 12,542,000,000 | 10,084,000,000 |
| Marketable Securities Non Current | 142,000,000 | 65,000,000 | 37,000,000 |
| Property Plant And Equipment | — | — | — |
| Other Assets Non Current | 138,000,000 | 143,000,000 | 123,000,000 |
| Total Assets Non Current | 2,857,000,000 | 2,350,000,000 | 2,230,000,000 |
| Total Assets | 15,630,000,000 | 14,892,000,000 | 12,314,000,000 |
| Accounts Payable | 1,331,000,000 | 1,252,000,000 | 889,000,000 |
| Deferred Revenue | 51,000,000 | 418,000,000 | 359,000,000 |
| Short Term Debt | 0 | 0 | 0 |
| Other Liabilities Current | — | — | — |
| Total Liabilities Current | 7,896,000,000 | 8,168,000,000 | 6,855,000,000 |
| Long Term Debt | 2,923,000,000 | 2,180,000,000 | 2,176,000,000 |
| Other Liabilities Non Current | 120,000,000 | 124,000,000 | 104,000,000 |
| Total Liabilities Non Current | 3,238,000,000 | 2,509,000,000 | 2,495,000,000 |
| Total Liabilities | 11,134,000,000 | 10,677,000,000 | 9,350,000,000 |
| Common Stock | 0 | 0 | 0 |
| Retained Earnings | 4,091,000,000 | 3,887,000,000 | 2,796,000,000 |
| Accumulated Other Comprehensive Income | -57,000,000 | -82,000,000 | -160,000,000 |
| Total Shareholders Equity | 4,496,000,000 | 4,215,000,000 | 2,964,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 186,000,000 | 171,000,000 | 176,000,000 |
| Share Based Compensation Expense | 116,000,000 | 115,000,000 | 103,000,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 78,000,000 | 778,000,000 | 95,000,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 115,000,000 | 328,000,000 | 55,000,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 644,000,000 | 1,662,000,000 | 773,000,000 |
| Purchases Of Marketable Securities | 1,132,000,000 | 1,433,000,000 | 1,913,000,000 |
| Sales Of Marketable Securities | 99,000,000 | 259,000,000 | 1,398,000,000 |
| Acquisition Of Property Plant And Equipment | 100,000,000 | 84,000,000 | 91,000,000 |
| Acquisition Of Business | 344,000,000 | 3,000,000 | 134,000,000 |
| Other Investing Activities | -1,000,000 | -4,000,000 | 50,000,000 |
| Cash From Investing Activities | -464,000,000 | -744,000,000 | -790,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 1,000,000,000 | 0 | 400,000,000 |
| Issuance Of Long Term Debt | 740,000,000 | 0 | 0 |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | -30,000,000 | 2,000,000 | 33,000,000 |
| Cash From Financing Activities | -347,000,000 | -58,000,000 | -441,000,000 |
| Change In Cash | -167,000,000 | 860,000,000 | -458,000,000 |
| Cash At End Of Period | 4,662,000,000 | 4,848,000,000 | 4,006,000,000 |
| Income Taxes Paid | 379,000,000 | 405,000,000 | 340,000,000 |
| Interest Paid | 121,000,000 | 108,000,000 | 108,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 20.52 | 18.91 | 13.72 |
| Price To Earnings Ratio | 14.1837 | 19.1068 | 24.0685 |
| Earnings Growth Rate | 8.514 | 37.828 | 20.3509 |
| Price Earnings To Growth Ratio | 1.6659 | 0.5051 | 1.1827 |
| Book Value Per Share | 78.3275 | 73.0503 | 51.2803 |
| Price To Book Ratio | 3.7158 | 4.946 | 6.4395 |
| Ebitda | 1,862,000,000 | 1,776,000,000 | 1,418,000,000 |
| Enterprise Value | 14,967,270,000 | 18,179,587,000 | 17,256,716,000 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.6501 | 0.5172 | 0.7341 |
| Capital Expenditures | — | — | — |
| Free Cash Flow | — | — | — |
| Return On Equity | 0.2622 | 0.2588 | 0.2672 |
| One Year Beta | 0.212 | 0.6289 | 0.5295 |
| Three Year Beta | 0.4881 | 0.6215 | 0.8523 |
| Five Year Beta | 0.787 | 0.8534 | 0.8811 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Schapiro Richard M | Director | 2025-11-24 | 357 | D | 11,352 |
| BRASIER BARBARA L | Director | 2025-10-01 | 285 | A | 4,859 |
| GROHOWSKI LEO P | Director | 2025-10-01 | 285 | A | 583 |
| Lockhart Stephen H | Director | 2025-10-01 | 285 | A | 3,425 |
| ORLANDO STEVEN J | Director | 2025-10-01 | 285 | A | 17,008 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Byron Donalds | 2025-10-07 | FL19 | Sale | 2025-09-04 | — | $1,001 - $15,000 |
| Byron Donalds | 2025-10-07 | FL19 | Sale | 2025-09-04 | Spouse | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-09-12 | CA31 | Purchase | 2025-08-05 | — | $1,001 - $15,000 |
| Rob Bresnahan | 2025-06-09 | PA08 | Purchase | 2025-05-15 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-06-06 | CA31 | Sale (Partial) | 2025-05-30 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 2025-09-30 | 43,486,249 | 227,248 | 191.3603 |
| CIBC Private Wealth Group LLC | 2025-09-30 | 538,296 | 2,813 | 191.3601 |
| Achmea Investment Management B.V. | 2025-09-30 | 1,109,000 | 5,797 | 191.3058 |
| Bell Investment Advisors, Inc | 2025-09-30 | 5,359 | 28 | 191.3929 |
| Caerus Investment Advisors, LLC | 2025-09-30 | 481,653 | 2,517 | 191.36 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| PRAXIS FUNDS | 2025-09-30 | Praxis Small Cap Index Fund Class I | MMSIX | 1,155 | 221,020.8 | 0.1109 |
| PRAXIS FUNDS | 2025-09-30 | Praxis Small Cap Index Fund Class A | MMSCX | 1,155 | 221,020.8 | 0.1109 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYVVX | 5,021 | 960,818.56 | 0.6686 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class A | RYLVX | 5,021 | 960,818.56 | 0.6686 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYZAX | 5,021 | 960,818.56 | 0.6686 |